HNRNPA3: A Non-Code RNA Molecule with Potential as A Drug Target and Biomarker

Target Name: HNRNPA3

NCBI ID: G220988

HNRNPA3

HNRNPA3: A Non-Code RNA Molecule with Potential as A Drug Target and Biomarker

HNRNPA3 (Human Nucleotide Repeat Domain-Containing RNA 3) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker in various diseases, including cancer. Its unique structure, which consists of a repeat of a core RNA secondary structure, makes it a unique molecule that has not been observed in any other organisms.

HNRNPA3 is a key regulator of gene expression in many organisms, including humans. It has been shown to play a role in the regulation of various cellular processes, including cell growth, apoptosis, and inflammation.

One of the most promising aspects of HNRNPA3 is its potential as a drug target. Its unique structure and the various functions that it has been shown to play make it an attractive target for small molecules. Many studies have identified potential small molecules that can interact with HNRNPA3 and modulate its function.

HNRNPA3 has also been shown to be a potential biomarker for various diseases, including cancer. Its unique structure and the various functions that it has been shown to play make it an attractive target for diagnostic tools.

In addition to its potential as a drug target and biomarker, HNRNPA3 is also of interest to researchers because of its unique structure and the various functions that it has been shown to play. This makes it a valuable tool for studying the regulation of gene expression and the role of non-coding RNAs in various cellular processes.

Overall, HNRNPA3 is a promising molecule that has the potential to be a drug target and biomarker. Further research is needed to fully understand its unique structure and the various functions that it has been shown to play.

Protein Name: Heterogeneous Nuclear Ribonucleoprotein A3

Functions: Plays a role in cytoplasmic trafficking of RNA. Binds to the cis-acting response element, A2RE. May be involved in pre-mRNA splicing

The "HNRNPA3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HNRNPA3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets